Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Submission of Press Release that is being issued in connection with the receipt of USFDA approval for Dasatinib Tablets by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company.